R
Robert Nakamura
Researcher at California Department of Public Health
Publications - 7
Citations - 235
Robert Nakamura is an academic researcher from California Department of Public Health. The author has contributed to research in topics: Medicine & Viral load. The author has an hindex of 4, co-authored 4 publications receiving 122 citations.
Papers
More filters
Journal ArticleDOI
Performance Characteristics of a Rapid Severe Acute Respiratory Syndrome Coronavirus 2 Antigen Detection Assay at a Public Plaza Testing Site in San Francisco.
Genay Pilarowski,Paul Lebel,Sara Sunshine,Jamin Liu,Emily D. Crawford,Carina Marquez,Luis Rubio,Gabriel Chamie,Jackie Martinez,James Peng,Douglas Black,Wesley Wu,John E. Pak,Matthew T. Laurie,Diane Jones,Steve Miller,Jon Jacobo,Susana Rojas,Susy Rojas,Robert Nakamura,Valerie Tulier-Laiwa,Maya L. Petersen,Diane V. Havlir,Joseph L. DeRisi +23 more
TL;DR: In this paper, the performance of the Abbott BinaxNOW rapid antigen test for coronavirus disease 2019 (Binax-CoV2) to detect virus among persons, regardless of symptoms, at a public plaza site of ongoing community transmission was evaluated.
Posted ContentDOI
Performance characteristics of a rapid SARS-CoV-2 antigen detection assay at a public plaza testing site in San Francisco
Genay Pilarowski,Paul Lebel,Sara Sunshine,Jamin Liu,Emily D. Crawford,Carina Marquez,Luis Rubio,Gabriel Chamie,Jackie Martinez,James Peng,Douglas Black,Wesley Wu,John E. Pak,Matthew T. Laurie,Diane Jones,Steve Miller,Jon Jacobo,Susana Rojas,Susy Rojas,Robert Nakamura,Valerie Tulier-Laiwa,Maya L. Petersen,Diane V. Havlir,Joseph L. DeRisi +23 more
TL;DR: The performance of the Abbott BinaxNOWTM Covid-19 rapid antigen test to detect virus among persons, regardless of symptoms, at a public plaza site of ongoing community transmission is evaluated.
Journal ArticleDOI
Estimation of secondary household attack rates for emergent spike L452R SARS-CoV-2 variants detected by genomic surveillance at a community-based testing site in San Francisco.
James Peng,Jamin Liu,Sabrina A Mann,Anthea M Mitchell,Matthew T. Laurie,Sara Sunshine,Genay Pilarowski,Patrick Ayscue,Amy Kistler,Manu Vanaerschot,Lucy M Li,Aaron McGeever,Eric D. Chow,Carina Marquez,Robert Nakamura,Luis Rubio,Gabriel Chamie,Diane Jones,Jon Jacobo,Susana Rojas,Susy Rojas,Valerie Tulier-Laiwa,Douglas Black,Jackie Martinez,Jamie Naso,Joshua Schwab,Maya L. Petersen,Diane V. Havlir,Joseph L. DeRisi,IDseq Team +29 more
TL;DR: In this paper, SARS-CoV-2 genomic sequences were generated from positive samples collected, along with epidemiological metadata, at a walk-up, rapid testing site in the Mission District of San Francisco, California during November 22-December 1, 2020 and January 10-29, 2021.
Journal ArticleDOI
Comparison of SARS-CoV-2 Reverse Transcriptase Polymerase Chain Reaction and BinaxNOW Rapid Antigen Tests at a Community Site During an Omicron Surge
John Schrom,Carina Marquez,Genay Pilarowski,Chung Yu Wang,A. Mitchell,Robert Puccinelli,Douglas Black,Susana Rojas,Salu Ribeiro,Valerie Tulier-Laiwa,Jackie Martinez,Joselin Payan,Susy Rojas,Diane Jones,Daniel Fernández de Luco Martínez,Robert Nakamura,Gabriel Chamie,Vivek Jain,Maya L. Petersen,Joe DeRisi,Diane V. Havlir +20 more
TL;DR: This study compares the performance of the BinaxNOW rapid antigen test versus reverse transcriptase polymerase chain reaction for community-based detection of infection with the Omicron variant of SARS-CoV-2 in San Francisco, California, during January 2022.
Posted ContentDOI
Estimation of secondary household attack rates for emergent SARS-CoV-2 variants detected by genomic surveillance at a community-based testing site in San Francisco
James Peng,Sabrina A Mann,Anthea M Mitchell,Jamin Liu,Matthew T. Laurie,Sara Sunshine,Genay Pilarowski,Patrick Ayscue,Amy Kistler,Manu Vanaerschot,Lucy M Li,Aaron McGeever,Eric D. Chow,IDseq Team,Carina Marquez,Robert Nakamura,Luis M. Rubio,Gabriel Chamie,Diane Jones,Jon Jacobo,Susana Rojas,Susy Rojas,Valerie Tulier-Laiwa,Douglas L. Black,Jackie Martinez,Jamie Naso,Joshua Schwab,Maya L. Petersen,Diane V. Havlir,Joseph L. DeRisi +29 more
TL;DR: In this paper, SARS-CoV-2 genomic sequences were generated from positive samples collected, along with epidemiological metadata, at a walk-up rapid testing site in the Mission District of San Francisco, California during November 22-December 2, 2020 and January 10-29, 2021.